Mercer - Talent. Health. Retirement. Investments
Talent. Health. Retirement. Investments

Final Approval of the Delaware Statewide Transition Plan

Delaware is only the sixth state to receive final approval

The State of Delaware announced recently that it has received CMS approval of its HCBS transition plan. Mercer is proud to have worked with Delaware over the past few months to respond to the outstanding CMS issues.  Read more

We are on the Road Again!

Mercer participates in and sponsors a number of health care conferences each year. Members of our leadership team will be at the following events and hope to see many of our country's top state officials. If you are interested in meeting with us during these events, feel free to contact us.
banner image not configured

NASHP Annual Conference

Mercer will facilitate a roundtable at the National Academy for State Health Policy conference on Medicaid and SUD.

View the Details button image
banner image not configured

NAMD Fall Conference

National Association of Medicaid Directors - Visit our Booth #66 or visit the NAMD conference page

We'll Be There button image
banner image not configured

2017 Past Conference Participation and Materials

Mercer participated in NASADAD, HSFO and NASUAD HCBS this year. Take a look at our HCBS MLTSS presentation

Mercer MLTSS button image

Stay Informed

Recent Mercer Communications

If you'd like to be included on future communications, please contact us to join our exclusive distribution list.



Mercer has been partnering with states and other stakeholder organizations for over 30 years to support health care programs for the low-income and most vulnerable populations in this country. We face an unprecedented environment of uncertainty and change in the Medicaid and CHIP programs, and yet, there is a need to keep moving forward. This newsletter shares information you need to move your health programs forward.


After a dramatic journey through the House and the Senate, Congressional efforts to repeal and replace the Affordable Care Act (ACA) are now stalled, with Medicaid a key focus of the Senate deliberations. At the time of the drafting of this article, Senate GOP leadership has announced plans to introduce a repeal and delay bill to repeal ACA but provide Congress...


 Overcoming the VBP Challenge will you maximize your Medicaid dollar while increasing access and quality in an uncertain healthcare environment?


Medicaid/CHIP Parity Compliance with Medicaid managed care organizations, alternative benefit plans, and separate CHIP programs are...


Quality Encounter Data encounter data can seem like an elusive unicorn in the health care world. However, having complete, accurate...


Medical Loss Ratio: Not as Bad as it Seems medical loss ratio requirements play a prominent role in the Centers for Medicare and Medicaid Services...


Management of Specialty Drug Trend drugs are generally considered to be high cost drugs that are used to treat complex, chronic, or rare medical...





On August 3rd, the Food and Drug Administration (FDA) approved Mavyret™ (mav-EH'-rit), a new product manufactured by Abbvie for the treatment of hepatitis C virus (HCV).  Mavyret™ is approved for the treatment of all six major HCV genotypes for both treatment naïve and treatment experienced patients. Mavyret™ is a combination of two new HCV antivirals, glecaprevir and pibrentasvir. An estimated 95% of patients with chronic hepatitis C in the U.S. could be candidates for treatment with Mavyret™. The list price of Mavyret™ is significantly lower than the list price for other HCV antiviral regimens.  

Mavyret™ is a game changer in the Hepatitis C market. Its approval for a short 8-week regimen for treatment naïve patients across all genotypes coupled with a list price that is less than half of the competition will position it well for preferred placement on Medicaid fee-for-service (FFS) and managed care formularies.  Abbvie representatives have stated publicly that they are focusing on getting coverage approved through the Medicaid, Medicare, and Veterans Administration markets. 

Read more about Indication and Use, Place in Therapy, and Cost

Impact of the New Administration on Medicaid

Mercer's Dedication to Keeping our Clients Informed

The outcomes of last month’s elections will certainly result in changes to the rules that govern/impact the health care system as a whole, including the Medicaid program. Although the details of those changes remain uncertain today, we want to assure our clients that we are actively exploring the possible changes that lie ahead and building the tools and resources our clients will need to assess these new policy directions. In the next few weeks and throughout the transition period post-inaguration, we will provide informational resources and updates. In the meantime, please contact us with your questions and concerns via email.

The AAA Health Practice Council Weighs in on the AHCA

Mercer contributes to the American Academy of Actuaries' letter on AHCA to House Speaker Ryan and House Democratic Leader Pelosi


A collaborative effort by individuals on the AAA Individual and Small Group Markets Committee, the Medicaid Subcommittee, along with Mercer staff.  View the letter here



Mercer Government Human Services Consulting provides a full range of consulting services.

More infobutton image


Policy and Operations

Rich in experience with strategic planning, interpretation and application of regulations and policy, managed care procurement, operations, waivers, financing, and rate setting.

More infobutton image


Actuarial and Financial

Mercer is well positioned to assist clients on a variety of topics ranging from traditional capitated rate setting to program development and compliance with these new health care delivery models.

More infobutton image

Mercer Contributes to NGA's Medicaid Compendium

Released in 2016, NGA's Medicaid Health Care Purchasing Compendium is "intended to serve as a reference guide for states when purchasing health care services for their Medicaid program..."
banner image not configured

The NGA Compendium

"States face the ongoing challenge of managing the costs of their Medicaid programs while ensuring beneficiaries have access to quality health care."

Read more information button image
banner image not configured

Section II - Federal Authorities and Compliance

Employees contributing to Compendium Section II include Leena Hiilivirta, Bill Lasowski and Stephanie Kurlanzik

View this section button image
banner image not configured

Section V - Financial Models

Including rate setting, risk adjustment, performance indicators. Contributors were Fred Gibison, Kevin Lurito, Gabe Smith, Doug Shannon, Amanda Rhodes

View Section V button image

An overview of our experience assisting government with their Medicaid and Medicare programs.

Our passion is to work as a team with our clients to help those in need throughout the country.

Mercer Government includes more than 15 former state and federal health care leaders and:
290+ Staff - 27 ASAs - 20 FSAs - 5 CPAs - 9 Clinicians - 6 Pharmacists

  Download overview